"10.1371_journal.pone.0082962","plos one","2013-12-31T00:00:00Z","Rob Hooft van Huijsduijnen; R Kiplin Guy; Kelly Chibale; Richard K Haynes; Ingmar Peitz; Gerhard Kelter; Margaret A Phillips; Jonathan L Vennerstrom; Yongyuth Yuthavong; Timothy N C Wells","Medicines for Malaria Venture (MMV), Geneva, Switzerland; St. Jude Childrens Research Hospital, Memphis, Tennessee, United States of America; Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa; Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa; Oncotest GmbH, Freiburg, Germany; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America; Department of Pharmaceutical Sciences, Nebraska Medical Center, Omaha, Nebraska, United States of America; BIOTEC, National Science and Technology Development Agency, Thailand Science Park, Pathumthani, Thailand","Conceived and designed the experiments: TNCW RHvH IP GK. Performed the experiments: IP GK. Analyzed the data: RHvH TNCW IP GK. Contributed reagents/materials/analysis tools: RKG KC RKH MAP JLV YY. Wrote the paper: RHvH.","The authors have the following interests. Ingmar Peitz and Gerhard Kelter are employed by Oncotest GmbH. Medicines for Malaria Venture is involved in supporting the development of some of these medicines. There are no patents or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Rob Hooft van Huijsduijnen","RHVH",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
